e-learning
resources
European Respiratory Review
2010
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Treatment of COPD: from pharmacological to instrumental therapies
Alifano M., Cuvelier A., Delage A., Roche N., Lamia B., Molano L. C., Couderc L-J, Marquette C-H, Devillier P.
Source:
Eur Respir Rev 2010; 19: 7-23
Journal Issue:
March 2010 - 19 (115)
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Alifano M., Cuvelier A., Delage A., Roche N., Lamia B., Molano L. C., Couderc L-J, Marquette C-H, Devillier P.. Treatment of COPD: from pharmacological to instrumental therapies. Eur Respir Rev 2010; 19: 7-23
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Pharmacological options for the treatment of COPD: present and future
Source: Annual Congress 2007 - PG6 - COPD: comprehensive clinical assessment and pharmacological and nonpharmacological therapy
Year: 2007
Recommendations for pharmacological treatment of exacerbations of COPD
Source: International Congress 2017 – Treatment and prevention of COPD exacerbation
Year: 2017
Chronic cough: Are we integrating non-pharmacological therapies into treatment plans?
Source: International Congress 2017 – Clinical challenges in chronic lung diseases
Year: 2017
Antibiotics as immunomodulators: a potential pharmacologic approach for ARDS treatment
Source: Eur Respir Rev, 30 (162) 210093; 10.1183/16000617.0093-2021
Year: 2021
Pharmacological strategies for self-management of asthma exacerbations
Source: Eur Respir J 2006; 28: 182-199
Year: 2006
Current opinion: Pharmacological approaches in asthma and COPD
Source: Breathe 2009; 6: 24-35
Year: 2009
Therapeutic options for COPD exacerbations
Source: International Congress 2014 – PG04 Update on COPD exacerbations
Year: 2014
Triple therapy in COPD: Oportunities and challenges
Source: Short Video Statement 2020
Year: 2020
Effects of pulmonary rehabilitation in COPD patients treated with different pharmacological associations
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015
Additive effect of targeted lung denervation plus drug in patients with COPD
Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis
Year: 2015
Individual dynamic of inflammatory markers as indicators of COPD treatment effectiveness
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Dose-FEV1 modeling to support future development of AZD2115, a dual acting bronchodilator for the treatment of COPD
Source: International Congress 2015 – New targets and modalities for the treatment of asthma and COPD
Year: 2015
Pharmacological actions of statins: potential utility in COPD
Source: Eur Respir Rev 2009; 18: 222-232
Year: 2009
Changes in inhalation therapy after combined assessment of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015
Bronchodiator therapy in COPD: physiological effects
Source: Breathe 2008; 4: 342-344
Year: 2008
Outcomes for COPD pharmacological trials: from lung function to biomarkers
Source: Eur Respir J 2008; 31: 416-469
Year: 2008
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept